SCHEMBL3235451

SCHEMBL3235451

[2H]C([2H])([2H])Oc1ccccc1OC(C(=O)O)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.54
POLB P06746 2/20 0.40
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HTT P42858 2/20 0.39
IRAK4 Q9NWZ3 1/20 0.39
LDHA P00338 1/20 0.38
LMNA P02545 2/20 0.38
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA7 P43166 2/20 0.37
CA9 Q16790 2/20 0.37
CA14 Q9ULX7 2/20 0.37
CA4 P22748 1/20 0.37
ALDH1A1 P00352 2/20 0.37
ACHE P22303 1/20 0.37
CYP2D6 P10635 1/20 0.36
BCHE P06276 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL628528 0.87 KMT2A (0.70) KMT2APOLBMTNR1AMTNR1BSMN1; SMN2
SCHEMBL13430584 0.83 KMT2A (0.47) KMT2APOLBMTNR1AMTNR1BSMN1; SMN2
SCHEMBL14026722 0.80 KMT2A (0.41) KMT2APOLBMTNR1AMTNR1BSMN1; SMN2
1,2-Dimethoxybenzene SCHEMBL31501593 0.76 CA1 (0.61) KMT2APOLBSMN1; SMN2HTTLMNA
1,2-Dimethoxybenzene SCHEMBL3661985 0.76 CA1 (0.61) KMT2APOLBSMN1; SMN2HTTLMNA
SCHEMBL9423878 0.76 KMT2A (0.46) KMT2ASMN1; SMN2HTTLMNACYP2D6
SCHEMBL9424144 0.75 L3MBTL1 (0.61) KMT2ALMNAALDH1A1KDM4EGAA
SCHEMBL3228799 0.73 KMT2A (0.57) KMT2APOLBMTNR1AMTNR1BSMN1; SMN2
SCHEMBL8434636 0.73 KMT2A (0.47) KMT2ALMNACYP1A2CYP2C19L3MBTL1
SCHEMBL23829938 0.72 HTT (0.59) KMT2AHTTLMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8080549-B2 Endothelin receptor antagonists CONCERT PHARMACEUTICALS, INC. (US) 2011-12-20 US disclosed
US-20100063076-A1 Endothelin receptor antagonists SUN PHARMACEUTICAL INDUSTRIES, INC. 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063076-A1 Endothelin receptor antagonists EDNRA, EDNRB, ECE1 KMT2A 3852/4885POLB 3137/4885MTNR1A 480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.